Cargando…

Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study

Background: This is a proof of concept, as a pilot study, with the aim to evaluate continuous glucose monitoring metrics (CGM) in subjects with type 2 diabetes (T2DM), treated with nutritional therapy and metformin, before and after testosterone replacement therapy (TRT). Methods: In this longitudin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Defeudis, Giuseppe, Maddaloni, Ernesto, Rossini, Giovanni, Di Tommaso, Alfonso Maria, Mazzilli, Rossella, Di Palma, Paolo, Pozzilli, Paolo, Napoli, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505941/ https://www.ncbi.nlm.nih.gov/pubmed/36142982 http://dx.doi.org/10.3390/jcm11185333

Ejemplares similares

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study
por: Nusca, Annunziata, et al.
Publicado: (2015)

Erectile dysfunction and diabetes: A melting pot of circumstances and treatments
por: Defeudis, Giuseppe, et al.
Publicado: (2021)

Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
por: Davidiuk, Andrew J., et al.
Publicado: (2016)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
por: Shin, Yu Seob, et al.
Publicado: (2019)

Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
por: Ide, Veerle, et al.
Publicado: (2020)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
por: de Almeida Ferreira, Maurício, et al.
Publicado: (2022)

The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes
por: Defeudis, Giuseppe, et al.
Publicado: (2022)

Testosterone replacement in 49,XXXXY syndrome: andrological, metabolic and neurological aspects
por: Mazzilli, Rossella, et al.
Publicado: (2015)

Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy
por: Surampudi, Prasanth N., et al.
Publicado: (2012)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

Does Testosterone Replacement Therapy Promote an Augmented Risk of Thrombotic Events in Thalassemia Major Male Patients with Hypogonadism?
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Symptomatic late-onset hypogonadism but normal total testosterone: the importance of testosterone annual decrease velocity
por: La Vignera, Sandro, et al.
Publicado: (2020)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients
por: Snyder, Grace, et al.
Publicado: (2016)

Effects of testosterone replacement on serotonin levels in the prostate and plasma in a murine model of hypogonadism
por: Mota, Paulo, et al.
Publicado: (2020)

Plasma Metabolomics Profile of “Insulin Sensitive” Male Hypogonadism after Testosterone Replacement Therapy
por: Zolla, Lello, et al.
Publicado: (2022)

Who are the fair candidates for testosterone replacement therapy in patients with late-onset hypogonadism symptoms?
por: Amano, Toshiyasu
Publicado: (2023)

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy
por: Graziani, Andrea, et al.
Publicado: (2023)

Erectile dysfunction as a marker of endocrine and glycemic disorders
por: Mazzilli, R., et al.
Publicado: (2022)

Testosterone-Associated Dietary Pattern Predicts Low Testosterone Levels and Hypogonadism
por: Hu, Tzu-Yu, et al.
Publicado: (2018)

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
por: Jones, T. Hugh, et al.
Publicado: (2011)

Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols
por: Sato, Naoko, et al.
Publicado: (2015)

Changes in left ventricular repolarization after short-term testosterone replacement therapy in hypogonadal males
por: Piccirillo, G., et al.
Publicado: (2019)

Testosterone Replacement Therapy in Hypogonadal Men and Myocardial Infarction Risk: Systematic Review & Meta-Analysis
por: Lee, Jun Hee, et al.
Publicado: (2021)

Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial
por: Pencina, Karol M., et al.
Publicado: (2023)

A Review of Testosterone Pellets in the Treatment of Hypogonadism
por: McCullough, Andrew
Publicado: (2014)

Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015)

Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review
por: Defeudis, Giuseppe, et al.
Publicado: (2022)

Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
por: Napoli, Nicola, et al.
Publicado: (2013)

Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic
por: Pozzilli, Paolo, et al.
Publicado: (2020)

Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model
por: Abdelhamed, Amr, et al.
Publicado: (2015)

Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
por: Lisco, Giuseppe, et al.
Publicado: (2020)

Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
por: Nusca, Annunziata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kepvlb764obop4pu7eqghob8s5